IHL 0.00% 4.1¢ incannex healthcare limited

IHL - INCANNEX NEWS ARTICLES

  1. 1,958 Posts.
    lightbulb Created with Sketch. 4359
    This thread has been created as a Resource, to make it easy for the new or prospective IHL shareholders to find some secondary news sources / news articles, other than the Announcements issued by the company on the ASX.

    Note: Some articles are written in conjunction with the company. Other articles maybe written independently.

    This thread is not meant to cross into the "Industry News thread", and is on the contrary focused on articles written solely about IHL. I have found some nuggets in the "direct quotes" from the CEO within each article.

    I have also tagged this thread with the Hot Copper "Biotech" topic.

    Feel free to add articles where you find Incannex mentioned...

    Headlines

    Incannex sets sights on US capital markets and prepares for a Nasdaq listing Click to View Article

    IHL’s global research team lays out the blueprint for its psilocybin therapy development pathway, shares climb Click to View Article

    A busy Q4 shows how Incannex Healthcare is laying the foundations for its clinically backed global growth strategy Click to View Article

    Incannex kicks off Phase 1 clinical trial for its anti-inflammatory treatment Click to View Article

    Incannex files global patent for its IHL-42X sleep apnoea treatment and receives ethics approval to administer to patients every day in an extension trial Click to View Article

    Incannex secures complete supply chain solution for its anti-inflammatory multi-use drug Click to View Article

    Why this hidden gem in the Incannex product suite could be a global market winner Click to View Article

    Global pharma leader Vectura will help Incannex develop its concussion treatment drug Click to View Article

    Incannex takes key step towards FDA approval for IHL-42X with new research partnership Click to View Article

    US banks closer to legally doing business with cannabis, as ASX-listed Incannex pushes its way into the country Click to View Article

    How Incannex is positioning to be the ‘next GW Pharma’, with CEO Joel Latham Click to View Article

 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.